首页> 美国卫生研究院文献>British Journal of Cancer >Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

【2h】

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

机译：高级别浆液性卵巢癌进展过程中肿瘤微血管密度的特征：临床病理影响（OCTIPS联盟研究）。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background High-grade serous ovarian cancer (HGSOC) intratumoural vasculature evolution remains unknown. The study investigated changes in tumour microvessel density (MVD) in a large cohort of paired primary and recurrent HGSOC tissue samples and its impact on patients’ clinico-pathological outcome.

机译：背景高度浆液性卵巢癌（HGSOC）肿瘤内脉管系统的演变仍然未知。该研究调查了大量成对的原发性和复发性HGSOC组织样本中肿瘤微血管密度（MVD）的变化及其对患者临床病理结果的影响。

著录项

期刊名称 British Journal of Cancer
作者
Ilary Ruscito; Dan Cacsire Castillo-Tong; Ignace Vergote; Iulia Ignat; Mandy Stanske; Adriaan Vanderstichele; Jacek Glajzer; Hagen Kulbe; Fabian Trillsch; Alexander Mustea; Caroline Kreuzinger; Pierluigi Benedetti Panici; Charlie Gourley; Hani Gabra; Marianna Nuti; Eliane T. Taube; Mirjana Kessler; Jalid Sehouli; Silvia Darb-Esfahani; Elena Ioana Braicu;
展开▼
作者单位

展开▼
年(卷),期 2018(119),3
年度 2018
页码 330–338
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium [J] . Ruscito Ilary, Castillo-Tong Dan Cacsire, Vergote Ignace, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：探索CD133 /醛 - 脱氢酶-1（ALDH1） - 阳性癌症状细胞的克隆演化从初发于经常性高级浆液癌（HGSOC）。卵巢癌治疗 - 创新模型的研究延长生存（八层）财团
2. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients - A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD) [J] . RuscitoI., DimitrovaD., VasconcelosI., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第12期

机译：高度浆液性卵巢癌患者BRCA1基因启动子甲基化状态-肿瘤库卵巢癌（TOC）和卵巢癌诊断协会（OVCAD）的研究
3. Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium [J] . Guan Jun, Darb-Esfahani Silvia, Richter Rolf, Journal of Cancer Research and Clinical Oncology . 2019,第4期

机译：血管内皮生长因子受体2（VEGFR2）与晚期高级浆液癌患者（HGSOC）的长期存活相关：肿瘤库卵巢癌（TOC）联盟的研究
4. Characterization of Precancerous Mutations in Ulcerative Colitis-Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing [D] . Baker, Kathryn Terese 2018

机译：溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
5. Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer [O] . Huan Wu, Rongrong Li, Zhiwei Zhang, 2020

机译：校正至：Kallistatin抑制高度浆液性卵巢癌的肿瘤进展和铂耐药性
6. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study). [O] . Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, 2018

机译：高级浆液癌进展过程中肿瘤微血管密度的特征：临床病理影响（八层联盟研究）。

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

摘要

著录项

相似文献

相关主题

期刊订阅